Sachem Head Capital Management LP Takes $52.73 Million Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sachem Head Capital Management LP acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,330,000 shares of the company's stock, valued at approximately $52,734,000. Acadia Healthcare accounts for 2.9% of Sachem Head Capital Management LP's holdings, making the stock its 12th biggest holding. Sachem Head Capital Management LP owned 1.43% of Acadia Healthcare as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ACHC. Wellington Management Group LLP increased its stake in Acadia Healthcare by 0.7% in the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock valued at $465,283,000 after buying an additional 76,490 shares during the last quarter. FMR LLC grew its holdings in shares of Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after acquiring an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Acadia Healthcare by 18.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after acquiring an additional 486,395 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after acquiring an additional 454,044 shares in the last quarter. Finally, Madison Avenue Partners LP acquired a new position in Acadia Healthcare during the fourth quarter valued at approximately $76,339,000.

Analysts Set New Price Targets

Several research analysts have weighed in on ACHC shares. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday. Mizuho lowered their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. KeyCorp cut their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Barclays lowered their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 14th. Finally, Royal Bank of Canada cut their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $47.94.

Acadia Healthcare Price Performance

Shares of ACHC stock traded down $0.65 during trading hours on Thursday, reaching $22.87. The company's stock had a trading volume of 531,409 shares, compared to its average volume of 2,293,047. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.40. The company has a market capitalization of $2.11 billion, a price-to-earnings ratio of 7.50, a PEG ratio of 1.46 and a beta of 1.01. The firm's 50 day simple moving average is $25.96 and its 200-day simple moving average is $35.22.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same period in the previous year, the firm posted $0.84 EPS. The firm's revenue was up .3% on a year-over-year basis. Sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.